AquaBounty Technologies is a biotechnology company focused on improving productivity in commercial aquaculture, a $100 billion industry and the fastest growing segment of the worldwide food industry. The company’s objective is the application of biotechnology to ensure the availability of high quality seafood to meet global consumer demand. The company is developing products to address critical production constraints in the most popular farmed species, focusing initially on salmon, trout and tilapia. Its AquAdvantage® fish program is based upon a single, specific molecular modification in fish that results in more rapid growth in early development.
Our mission is to play a significant part in “The Blue Revolution” – bringing together biological sciences and molecular technology to enable an aquaculture industry capable of large-scale, efficient, and environmentally sustainable production of high quality seafood. Increased growth rates, enhanced resistance to disease, better food-conversion rates, manageable breeding cycles, and more efficient use of aquatic production systems are all important components of a sustainable aquaculture industry of the future.
AquaBounty was originally incorporated in1991, under the name A/F Protein, to pursue the commercial development of antifreeze protein-based technology under license from the University of California at Berkeley.
In 1996, A/F Protein acquired a license to the AquAdvantage technology from the University of Toronto and Memorial University of Newfoundland, and was subsequently reorganized in 2000, into two separate entities: A/F Protein, which retained the antifreeze protein technology; and, AquaBounty Farms, which obtained the AquAdvantage® technology.
AquaBounty Farms, headquartered in Waltham, Massachusetts, changed its name in 2004 to AquaBounty Technologies.
In 2006, AquaBounty Technologies was listed in the London Stock Exchange’s Alternative Investment Market (AIM) raising $28 million in an initial public offering of stock.